Broader whole-exome sequencing of pre-treatment tumors in 44 patients indicated a landscape of mutational signatures consisting predominantly of age, APOBEC, MMR etiologies as well as a smoking signature in select RET fusion-positive lung cancers with a history of smoking, but was otherwise unremarkable (Supplemental Table 3). Here, RET is linked to lung carcinoma.